Sarah Boden

speaker
98 appearances 1 recordings 1 series first heard Jul 2026 last heard 22 Jul

Sarah Boden’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
1 · Jul OctJan 26AprJulnow

Recordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.

Appearances

newest first · ▶ plays the moment
And this might encourage even more people to use them.
And again, these are experimental drugs.
We don't know a lot about them.
So Howard says that if the FDA decides to open the door to peptides, the proposed rule could come by the end of the year.
Of course, there will be a public comment period, so that means the final rule would be sometime next year.
And even if this regulatory stuff goes really smoothly...
Scott Bruner says supply chains will need some time to get up and running.
No.
No.
I mean, if it works the way Scott envisions, you would need a prescription.
And because peptides are experimental, it's unlikely that insurance will pay for your peptides.
So it probably won't be cheap.
So I want to emphasize this is all hypothetical.
Nobody knows what's going to happen.
But if the only people who can buy peptides from a compounding pharmacy are the people who can pay out of pocket for specialized medical care,
it's conceivable that there will still be demand for gray market peptides.
I had a great time.
Thanks for having me.
Showing 81–98 of 98 · page 5 of 5 ← Previous